Skip to main content

Table 2 Microbiological findings

From: Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria

Microbiological, n (%)

Patients with isolated microorganism

305 (58.9)

Patients with at least one MDR organism

88 (17.0)

Patients with at least one ESBL organism

50 (9.7)

E. coli ESBL +

43 (8.3)

Methicillin-resistant S. aureus

20 (3.9)

Proteus spp MDR +

5 (1)

K. pneumoniae ESBL +

7 (1.4)

K. pneumomiae carbapenemase producer

6 (1.2)

P. aeruginosa MDR+

4 (0.8)

Enterococcus spp MDR+

2 (0.4)

Enterobacter spp MDR +

2 (0.4)

Stenotrophomonas maltophilia MDR+

1 (0.2)

E. coli ESBL -

77 (14.9)

Methicillin-sensible S. aureus

24 (4.6)

S. pneumoniae

24 (4.6)

K. pneumoniae ESBL-

17 (3.3)

P. aeruginosa MDR-

25 (4.8)

Candida spp

12 (2.3)

Enterococcus spp MDR-

10 (1.9)

Proteus spp MDR-)

9 (1.7)

Enterobacter spp MDR-

5 (1)

N. meningitides

3 (0.6)

Bacteroides spp

1 (0.2)

Providencia spp

2 (0.4)

Stenotrophomonas maltophilia MDR-

3 (0.6)

C. difficile

4 (0.8)

Aspergillus spp

2 (0.4)

Acinetobacter baumanii

1 (0.2)

Salmonella group B

2 (0.4)

H. influenzae

1 (0.2)

Acinetobacter iwoffii

1 (0.2)

Propiniobacterium

1 (0.2)

Serratia spp

2 (0.4)

Polymicrobial infection

29 (5.6)

  1. n number, ESBL extended spectrum beta lactamase, MDR multi-drug resistant, spp species